MEDIVIR AB

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 55200
 
 
 
C07D HETEROCYCLIC COMPOUNDS 26136
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 986
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 990
 
 
 
C07K PEPTIDES 6130
 
 
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 367
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0036,330 NUCLEOTIDE PHOSPHORAMIDATE FORMULATIONMar 02, 16Feb 08, 18[A61K]
2017/0334,867 PROTEASE INHIBITORSAug 02, 17Nov 23, 17[C07D]
2017/0114,029 TREATMENT OF CHAGAS DISEASEJun 09, 15Apr 27, 17[C07D]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9856265 Macrocyclic inhibitors of hepatitis C virusMar 09, 17Jan 02, 18[A61K, C07D]
9828408 HCV polymerase inhibitorsNov 23, 16Nov 28, 17[C07H]
9708332 Respiratory syncytial virus inhibitorsOct 29, 13Jul 18, 17[A61K, C07D, A61P]
9650388 Form 2 crystalline polymorph of a salt of N-[1-6-(ethynyl-3-oxo-hexahydro-furo[3,2-B]pyrrole-4-carbonyl)-3-methyl-butyl]-4-[5-fluoro-2-(4-methyl-piperazinyl) thiazol-4-yl]-benzamide useful as cysteine protease inhibitorAug 13, 14May 16, 17[A61K, C07D]
9623022 Macrocyclic inhibitors of hepatitis C virusApr 25, 16Apr 18, 17[A61K, C07D, C07K]
9540411 HCV polymerase inhibitorsJul 14, 16Jan 10, 17[C07H]
9481703 HCV polymerase inhibitorsFeb 27, 15Nov 01, 16[C07H, A61K]
9428517 Protease inhibitorsNov 13, 15Aug 30, 16[C07D]
9353103 Macrocyclic inhibitors of hepatitis C virusApr 13, 15May 31, 16[A61K, C07D, C07K]
9200006 Protease inhibitorsApr 09, 14Dec 01, 15[C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0166,538 PROTEASE INHIBITORSAbandonedAug 25, 16Jun 15, 17[C07D]
2016/0271,160 HCV POLYMERASE INHIBITORSAbandonedOct 16, 14Sep 22, 16[A61K, C07H]
2014/0066,398 HCV POLYMERASE INHIBITORSAbandonedOct 10, 13Mar 06, 14[C07H, A61K]
2013/0217,646 COMBINATION OF ALOVUDINE AND ZIDOVUDINE IN A MOLAR RATIO OF 1:100 TO 1:350AbandonedFeb 01, 13Aug 22, 13[A61K]
2013/0143,835 HCV Polymerase InhibitorsAbandonedDec 04, 12Jun 06, 13[C07H]
2013/0028,865 Combination of a Macrocyclic Inhibitor of HCV, A Non-Nucleoside and a NucleosideAbandonedApr 13, 11Jan 31, 13[A61K, A61P]
2013/0005,730 NOVEL 1,3-OXAZOLIDINE COMPOUNDS AND THEIR USE AS RENIN INHIBITORSAbandonedOct 29, 10Jan 03, 13[A61K, C07D, A61P]
8338471 (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitorsExpiredAug 31, 11Dec 25, 12[A61K, C07D]
2012/0309,705 NOVEL 3'-DEOXY-3'-METHYLIDENE-BETA-L-NUCLEOSIDESAbandonedDec 14, 10Dec 06, 12[A61K, C07H, C07F, C07D, A61P]
2012/0123,119 ACYCLIC NUCLEOSIDE DERIVATIVESAbandonedJan 20, 12May 17, 12[C07D]
2012/0115,807 COMBINATION OF ALOVUDINE AND ZIDOVUDINE IN A MOLAR RATIO OF 1:100 TO 1:350AbandonedJan 17, 12May 10, 12[A61K, A61P]
8143396 1-[2′, 3′ -dideoxy-3′ C- (hydroxymethyl)—beta-D-erythro-pentofuranosyl] cytosine derivatives as HIV inhibitorsExpiredDec 30, 10Mar 27, 12[C07D]
8124609 Acyclic nucleoside derivativesExpiredOct 03, 08Feb 28, 12[A61K]
8022092 (2,5-dioxoimidazolidin-1-yl)-N-hydroxy-acetamides as metalloproteinase inhibitorsExpiredDec 13, 06Sep 20, 11[A61K, C07D]
8017620 Dutpase inhibitorsExpiredAug 03, 10Sep 13, 11[A61K, C07D]
2011/0112,089 Cysteine Protease InhibitorsAbandonedJan 19, 11May 12, 11[A61K, A61P]
7888367 1-[2′,3′ -dideoxy-3′ C-(hydroxymethyl)—beta-D-erythro-pentofuranosyl] cytosine derivatives as HIVExpiredJul 05, 06Feb 15, 11[A61K, C07D]
7829548 Compounds useful in the treatment of HIVExpiredDec 28, 05Nov 09, 10[A61K, A01N]
7825238 Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosineExpiredJan 18, 06Nov 02, 10[C07H, C07C]
7807677 HIV protease inhibitorsExpiredFeb 09, 06Oct 05, 10[A61K, C07D, C07C]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.